Stockscreener 앱 받기
17.14
12.32%
1.88
시간 외 거래:
17.15
0.010
+0.06%
전일 마감가:
$15.26
열려 있는:
$17.01
하루 거래량:
803.61K
Relative Volume:
1.68
시가총액:
$459.65M
수익:
$31.38M
순이익/손실:
$-6.69M
주가수익비율:
-65.92
EPS:
-0.26
순현금흐름:
$-1.84M
1주 성능:
+21.30%
1개월 성능:
+8.48%
6개월 성능:
-3.16%
1년 성능:
+373.48%
1일 변동 폭
$14.73
$17.20
1주일 범위
$13.98
$17.20
52주 변동 폭
$3.52
$21.48
Eton Pharmaceuticals Inc Stock (ETON) Company Profile
명칭
Eton Pharmaceuticals Inc
전화
(847) 787-7361
주소
21925 W. FIELD PARKWAY, DEER PARK, IL
ETON을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ETON
Eton Pharmaceuticals Inc
|
17.14 | 409.24M | 31.38M | -6.69M | -1.84M | -0.26 |
|
ZTS
Zoetis Inc
|
147.35 | 64.93B | 9.39B | 2.61B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.44 | 45.07B | 29.98B | 958.27M | 5.31B | 0.2964 |
|
HLN
Haleon Plc Adr
|
9.54 | 41.53B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.37 | 18.37B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
301.50 | 13.68B | 2.99B | 1.21B | 1.13B | 25.06 |
Eton Pharmaceuticals Inc Stock (ETON) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-01-23 | 재확인 | H.C. Wainwright | Buy |
| 2025-01-10 | 개시 | B. Riley Securities | Buy |
| 2025-01-06 | 재확인 | H.C. Wainwright | Buy |
| 2024-09-04 | 재개 | H.C. Wainwright | Buy |
| 2024-05-06 | 개시 | Craig Hallum | Buy |
| 2021-10-14 | 재개 | B. Riley Securities | Buy |
| 2021-01-04 | 재확인 | H.C. Wainwright | Buy |
| 2019-09-20 | 개시 | B. Riley FBR | Buy |
| 2019-06-10 | 개시 | H.C. Wainwright | Buy |
모두보기
Eton Pharmaceuticals Inc 주식(ETON)의 최신 뉴스
Eton Pharmaceuticals (NASDAQ:ETON) Downgraded to "Hold" Rating by Wall Street Zen - MarketBeat
Eton targets $80M revenue run-rate in Q3 2025 as product launches accelerate - MSN
Tools to monitor Eton Pharmaceuticals Inc. recovery probabilityWeekly Breakout Forecast with Entry Zones - Newser
Is Eton Pharmaceuticals Inc. stock reversal real or fakeTrade Safety Matrix for Conservative Traders - Newser
Eton (ETON) Q2 Revenue Jumps 108% - AOL.com
Quantitative breakdown of Eton Pharmaceuticals Inc. recent moveFree Stock Selection With High Accuracy - Newser
What does recent volatility data suggest for Eton Pharmaceuticals Inc.Free Secure Capital Picks With Upside Potential - Newser
Wall Street Zen Downgrades Eton Pharmaceuticals (NASDAQ:ETON) to Hold - Defense World
Published on: 2025-08-08 22:55:40 - Newser
What makes Eton Pharmaceuticals Inc. stock price move sharplyFree Capital Growth With Controlled Risk Picks - Newser
Eton Pharmaceuticals 2025 Q2 Earnings Narrowed Losses and Strong Revenue Growth - AInvest
What institutional flow reveals about Eton Pharmaceuticals Inc.Swing Candidate List with Trade Cues - Newser
Earnings call transcript: Eton Pharmaceuticals Q2 2025 reports strong growth By Investing.com - Investing.com Canada
Earnings call transcript: Eton Pharmaceuticals Q2 2025 reports strong growth - Investing.com
Eton Pharmaceuticals Soars 17.23% on 108% Sales Growth - AInvest
Eton Pharmaceuticals: Growth At A Reasonable Price, Or Maybe Even Better With Options - Seeking Alpha
Eton Pharmaceuticals Inc (ETON) Q2 2025 Earnings Call Highlights: Record Revenue Growth and ... By GuruFocus - Investing.com Canada
Eton Pharmaceuticals Reports Robust Q2 2025 Growth - TipRanks
Real time pattern detection on Eton Pharmaceuticals Inc. stockBuy/Sell Zone Confirmation Technical Analysis - Newser
Why Eton Pharmaceuticals Inc. is moving todayYield Curve Outlook and Long-Term Implication Summary - Newser
Eton Pharmaceuticals Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Eton Pharmaceuticals reports Q2 non-GAAP EPS 3c, consensus 2c - TipRanks
Eton Pharmaceuticals earnings beat by $0.02, revenue topped estimates - Investing.com Canada
Eton Pharmaceuticals Reports Second Quarter 2025 Financial Results - GlobeNewswire
Signal strength of Eton Pharmaceuticals Inc. stock in tech scannersLow Risk High Confidence Watchlist Builder - Newser
Smart tools for monitoring Eton Pharmaceuticals Inc.’s price actionAI-Powered Stock Trend Movement Analysis - Newser
Quant Tools Rank Eton Pharmaceuticals Inc. as High Risk High RewardVerified Signal From Chart Patterns Detected - beatles.ru
How does Eton Pharmaceuticals Inc. compare to its industry peersMarket-leading profit generation - Jammu Links News
How many analysts rate Eton Pharmaceuticals Inc. as a “Buy”Get daily expert analysis for smarter investing - Jammu Links News
What is the risk reward ratio of investing in Eton Pharmaceuticals Inc. stockFree Stock Market Trend Analysis - Jammu Links News
How volatile is Eton Pharmaceuticals Inc. stock compared to the marketBoost your wealth with consistent growth stocks - Jammu Links News
Is Eton Pharmaceuticals Inc. a good long term investmentFree Stock Market Query - Jammu Links News
Is Eton Pharmaceuticals Inc. stock overvalued or undervaluedInvest smarter with actionable trading signals - Jammu Links News
Why is Eton Pharmaceuticals Inc. stock attracting strong analyst attentionAchieve consistent profits with smart trading - Jammu Links News
What catalysts could drive Eton Pharmaceuticals Inc. stock higher in 2025Track stocks with high upside potential easily - Jammu Links News
What are the technical indicators suggesting about Eton Pharmaceuticals Inc.Get exclusive market analysis for investors - Jammu Links News
What is the dividend policy of Eton Pharmaceuticals Inc. stockUnlock daily trading alerts for profits - Jammu Links News
Eton Pharmaceuticals Inc. Stock Analysis and ForecastBreakout stock performance - Jammu Links News
Eton Pharmaceuticals, Inc. (ETON) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release - Yahoo Finance
Published on: 2025-07-30 01:43:42 - metal.it
Short Term Charts Align With Long Term Uptrend in Eton Pharmaceuticals Inc.Conservative Long Term Growth Plans Under Review - metal.it
RSI and MACD Indicate Shift in Eton Pharmaceuticals Inc. SentimentHigh Growth Low Risk Stock Selection Gets Analyst Nod - metal.it
How to interpret RSI for Eton Pharmaceuticals Inc. stockFree Step-by-Step Trade Signal Implementation - Newser
Eton Pharmaceuticals to Report Second Quarter 2025 Financial Results on Thursday, August 7, 2025 - GlobeNewswire
Eton Pharmaceuticals, Rare Disease Leader, Announces Q2 2025 Earnings Call Details for August 7 - Stock Titan
How Eton Pharmaceuticals Inc. stock reacts to Fed policy changesAlpha Stock Picks with Chart Confirmation - Newser
Is it the right time to buy Eton Pharmaceuticals Inc. stockCapitalize on market momentum for profits - jammulinksnews.com
Eton Pharmaceuticals Inc (ETON) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.43%
0.47%
자본화:
|
볼륨(24시간):